SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Frankfurt
Börse Börse Frankfurt
Symbol BM8
EUR
  • Biomarin Pharmaceutical
    Börse Börse Frankfurt
    Symbol BM8
    EUR
  • Biomarin Pharmaceutical
    Börse Börse Berlin
    Symbol BM8
    EUR
  • Biomarin Pharmaceutical
    Börse Börse München
    Symbol BM8
    EUR
  • BIOMARIN PHARMACEUTICAL INC
    Börse Gettex System der Börse München
    Symbol BM8
    EUR
  • BIOMARIN PHARMACEUTICAL INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol BM8
    EUR
  • BIOMARIN PHARMACEUTICAL INC
    Börse Börse Düsseldorf
    Symbol BM8
    EUR
  • BIOMARIN PHARMACEUTICAL INC
    Börse Börse Stuttgart
    Symbol BM8
    EUR
  • BIOMARIN PHARMACEUTICAL INC
    Börse Quotrix System der Börse Düsseldorf
    Symbol BM8
    EUR
  • ISIN US09061G1013 WKN: 924801
    Symbol BMRN
    USD
  • Symbol BM8
  • USD
Symbol BM8
Währung EUR
Börse Börse Frankfurt Zeitzone: Europe/London
Marktkapitalisierung 12.693.260.929 (+- 16%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

14.747.496.448 oder 12.105.000.000 oder 11.227.286.340

Mitarbeiter 3.023 (+- 1%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

3.001 oder 3.045 Mitarbeiter

Anzahl Aktien 179.838.000
KGV 15.66 (+- 14%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

17.82 oder 13.5

EBITDA 35.086.000
PEGRatio 1.0134
Buchwert 22.336

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 66,42 EUR -0,30% 

Aktionärsstruktur der BioMarin Pharmaceutical Inc

25 News & Informationen zur Biomarin Pharmaceutical Aktie

  • Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
    financialpost.com

    Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

    – $6.6 million in net revenue for the second quarter 2021 (624% increase from first quarter 2021) – – 415 patient start forms (PSFs) received for LUPKYNIS™…

  • EDGAR Filing Documents for 0001048477-21-000025
    sec.gov

  • BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaimé on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaimé on Q2 2021 Results – Earnings Call Transcript

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2021 Results Conference Call July 28, 2021 04:30 PM ET Company Participants Traci McCarty – VP, IR J.J.

  • The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
    markets.businessinsider.com

    The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

    Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…

  • Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out for
    zacks.com

    Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out for

    BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • EMA Validates BioMarin' MAA For Valoctocogene Roxaparvovec To Treat Severe Hemophilia A
    markets.businessinsider.com

    EMA Validates BioMarin' MAA For Valoctocogene Roxaparvovec To Treat Severe Hemophilia A

    (RTTNews) – The European Medicines Agency or EMA validated BioMarin Pharmaceutical Inc.'s (BMRN) Marketing Authorization Application or MAA for it…

  • 10 Stocks Stanley Druckenmiller is Selling
    insidermonkey.com

    10 Stocks Stanley Druckenmiller is Selling

    In this article, we discuss the 10 stocks Stanley Druckenmiller is selling. If you want to skip our detailed analysis of Druckenmiller’s history, investment…

  • Where Do Hedge Funds Stand On Whirlpool Corporation (WHR)?
    insidermonkey.com

    Where Do Hedge Funds Stand On Whirlpool Corporation (WHR)?

    How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…

  • S&P's Record Run Ends, but the NASDAQ Keeps Going
    investing.com

    S&P's Record Run Ends, but the NASDAQ Keeps Going

    Stocks Analysis by Zacks Investment Research covering: Steel Dynamics Inc, Apple Inc, Amazon.com Inc, Cleveland-Cliffs Inc. Read Zacks Investment Research's latest article on Investing.com

  • Is The J.M. Smucker Company (SJM) Going to Burn These Hedge Funds?
    insidermonkey.com

    Is The J.M. Smucker Company (SJM) Going to Burn These Hedge Funds?

    How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…

  • Locanabio Expands Leadership Team With Appointment Of Chief Scientific Officer And Chief Medical Officer
    thestreet.com

    Locanabio Expands Leadership Team With Appointment Of Chief Scientific Officer And Chief Medical Officer

    SAN DIEGO, July 6, 2021 /PRNewswire/ — Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with

  • BioMarin Announces 12 Presentations at the International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress
    prnewswire.com

    BioMarin Announces 12 Presentations at the International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress

    /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced three oral presentations and nine poster presentations related to valoctocogene…

  • Sarepta, Vertex, Neurocrine: There’s Deep Value In These Beaten Down Healthcare Stocks
    forbes.com

    Sarepta, Vertex, Neurocrine: There’s Deep Value In These Beaten Down Healthcare Stocks

    Our theme of Out Of Favor Health Care Stocks includes healthcare and pharma names that are seeing a disconnect between their financial performance and stock price returns. Specifically, the theme filters for healthcare companies that have grown revenue by at least 50% over the last three years…

  • BioMarin Pharmaceutical : Resubmits Marketing Authorization Application (MAA) to European Medicines Agency for Valoctocogene Roxaparvovec...
    marketscreener.com

    BioMarin Pharmaceutical : Resubmits Marketing Authorization Application (MAA) to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A

    SAN RAFAEL, Calif., June 28, 2021 /PRNewswire/ — BioMarin Pharmaceutical Inc. announced today that the company resubmitted a Marketing Authorization Application to the European Medicines Agency … | June 28, 2021

  • Global Phenylketonuria Treatment Market (2021 to 2026) - by Type, Route, End-user and Geography
    markets.businessinsider.com

    Global Phenylketonuria Treatment Market (2021 to 2026) – by Type, Route, End-user and Geography

    DUBLIN, June 25, 2021 /PRNewswire/ — The 'Global Phenylketonuria Treatment Market (2021-2026) by Type, Route, End-user, Geography, Competitive An…

  • Hedge Funds Have Never Been This Bullish On Pool Corporation (POOL)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Pool Corporation (POOL)

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….

  • Is PulteGroup, Inc. (PHM) A Good Stock To Buy?
    insidermonkey.com

    Is PulteGroup, Inc. (PHM) A Good Stock To Buy?

    With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred…

  • Gritstone Announces Management Changes, Including
    globenewswire.com

    Gritstone Announces Management Changes, Including

    EMERYVILLE, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next…

  • Hedge Funds Have Never Been This Bullish On Howmet Aerospace Inc. (HWM)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Howmet Aerospace Inc. (HWM)

    In this article we are going to use hedge fund sentiment as a tool and determine whether Howmet Aerospace Inc. (NYSE:HWM) is a good investment right now…

  • Parnassus Endeavor Fund Buys Verizon Communications Inc, S&P Global Inc, Omnicom Group Inc, Sells Micron Technology Inc, Applied Materials...
    gurufocus.com

    Parnassus Endeavor Fund Buys Verizon Communications Inc, S&P Global Inc, Omnicom Group Inc, Sells Micron Technology Inc, Applied Materials Inc, Lam Research Corp

    Parnassus Endeavor Fund Buys Verizon Communications Inc, S&P Global Inc, Omnicom Group Inc, Sells Micron Technology Inc, Applied Materials Inc, Lam Research Corp, Stocks: HBI,ILMN,VZ,SPGI,OMC,BIIB,BMRN,NVS,MU,AMAT,LRCX,SC, release date:Apr 12, 2021

  • Rectangle Pattern Suggests a Momentous Move in BioMarin Pharmaceutical Stock Soon By StockNews
    investing.com

    Rectangle Pattern Suggests a Momentous Move in BioMarin Pharmaceutical Stock Soon By StockNews

    Rectangle Pattern Suggests a Momentous Move in BioMarin Pharmaceutical Stock Soon

  • BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of...
    marketscreener.com

    BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into BioMarin… | January 16, 2021

  • Stock Alert: BioMarin Pharma Tumbles 8%
    rttnews.com

    Stock Alert: BioMarin Pharma Tumbles 8%

    Shares of BioMarin Pharmaceutical Inc. (BMRN) are falling more than 8 percent or $7.67 in Monday's morning trade at $82.19. Sunday, BioMarin announced positive phase 3 gene therapy trial results in adults with severe hemophilia A, noting that the study met all primary and secondary efficacy endpoints in one-year data set.

  • Primecap Curbs Holdings of Cree, BioMarin Pharmaceutical
    gurufocus.com

    Primecap Curbs Holdings of Cree, BioMarin Pharmaceutical

    Primecap Curbs Holdings of Cree, BioMarin Pharmaceutical, Stocks: CREE,BMRN,FGEN,LLY,ADBE,MSFT,BIIB,AMGN, PRIMECAP Management, release date:Jan 08, 2021

  • BioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021?
    forbes.com

    BioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021?

    Our theme of Out Of Favor Health Care Stocks includes health care names that have witnessed strong growth and improving fundamentals over the last few years but have still underperformed over 2020, partly due to Covid-19 related disruptions of the health care industry…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen BioMarin Pharmaceutical Inc am höchsten gewichtet ist Insgesamt in 30 ETFs enthalten

Dir gefallen die Informationen zu Biomarin Pharmaceutical?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Biomarin Pharmaceutical?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Biomarin Pharmaceutical?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Biomarin Pharmaceutical?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero